PT1301537E - Péptidos e sua utilização em ensaios para doença cardiovascular - Google Patents

Péptidos e sua utilização em ensaios para doença cardiovascular Download PDF

Info

Publication number
PT1301537E
PT1301537E PT01949734T PT01949734T PT1301537E PT 1301537 E PT1301537 E PT 1301537E PT 01949734 T PT01949734 T PT 01949734T PT 01949734 T PT01949734 T PT 01949734T PT 1301537 E PT1301537 E PT 1301537E
Authority
PT
Portugal
Prior art keywords
assays
peptides
cardiovascular disease
cyclised
affinity
Prior art date
Application number
PT01949734T
Other languages
English (en)
Portuguese (pt)
Inventor
Seppo Yla-Herttuala
Outi Narvanen
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Publication of PT1301537E publication Critical patent/PT1301537E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT01949734T 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular PT1301537E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use

Publications (1)

Publication Number Publication Date
PT1301537E true PT1301537E (pt) 2008-12-04

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01949734T PT1301537E (pt) 2000-07-18 2001-07-18 Péptidos e sua utilização em ensaios para doença cardiovascular

Country Status (12)

Country Link
US (2) US20040091934A1 (https=)
EP (1) EP1301537B1 (https=)
JP (1) JP2004504327A (https=)
AT (1) ATE408626T1 (https=)
AU (1) AU2001270851A1 (https=)
CA (1) CA2417789A1 (https=)
DE (1) DE60135846D1 (https=)
DK (1) DK1301537T3 (https=)
ES (1) ES2312455T3 (https=)
GB (1) GB0017641D0 (https=)
PT (1) PT1301537E (https=)
WO (1) WO2002006314A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
PL372925A1 (en) 2001-09-28 2005-08-08 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
JP2007531537A (ja) 2004-04-06 2007-11-08 セダーズ−シナイ メディカル センター アポリポタンパク質a−iおよびアポリポタンパク質a−imilanoをコードする組換えアデノ随伴ウイルスベクターによる血管疾患の予防および処置
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
CA2669863A1 (en) * 2006-12-22 2008-07-03 Abbott Laboratories Cardiovascular autoimmune disease panel and methods of using same
CN103501806A (zh) 2010-11-12 2014-01-08 赛达斯西奈医疗中心 用于治疗和/或预防动脉瘤的免疫调节方法和系统
RU2013126626A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения гипертензий
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
US10434141B2 (en) 2016-05-31 2019-10-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
EP1021728B8 (en) * 1997-06-20 2008-04-23 Leuven Research & Development VZW Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
US20080261234A1 (en) 2008-10-23
US20040091934A1 (en) 2004-05-13
AU2001270851A1 (en) 2002-01-30
EP1301537B1 (en) 2008-09-17
WO2002006314A2 (en) 2002-01-24
ES2312455T3 (es) 2009-03-01
GB0017641D0 (en) 2000-09-06
ATE408626T1 (de) 2008-10-15
CA2417789A1 (en) 2002-01-24
WO2002006314A3 (en) 2002-04-18
EP1301537A2 (en) 2003-04-16
DE60135846D1 (de) 2008-10-30
DK1301537T3 (da) 2008-12-08
JP2004504327A (ja) 2004-02-12

Similar Documents

Publication Publication Date Title
PT1301537E (pt) Péptidos e sua utilização em ensaios para doença cardiovascular
Cunningham et al. Proline specific peptidases
GB9812523D0 (en) Peptide inhibitors of hepatitis c virus ns3 protease
AU2002249837A1 (en) Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
DE60144145D1 (de) Subtilisin-variante
MA26221A1 (fr) Nouveaux preconcentres de microemulsion d'analogue de la cyclosporine.
ATE498011T1 (de) Modifizierte embryonale stammzellen und embryonales stammzellspezifisches gen
WO2002006457A3 (en) Novel lipase genes
EP1053315A4 (en) HUMAN 'HAARLOS' GENE AND PROTEIN AND THEIR USE
WO2002018635A8 (en) Use of nonviable particles comprising an internal control (ic) nucleic acid
KR880701728A (ko) 조직-형 및 우로키나제-형 플라스 미노겐 활성체 억제제의 진단검정 방법 및 억제제의 암호화 유전자
WO2001075157A1 (en) Probe for constructing probe polymer, method of constructing probe polymer and utilization thereof
Tsushima et al. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
DE69831229D1 (de) Schnelle bestimmung des verhältnisses von biologischen molekülen
WO2001056456A3 (en) Methods and compositions for detection of disease
WO2003002730A3 (fr) Methode de detection de l'activite de la calpaine 3 dans un echantillon biologique et peptides pour la mise en oeuvre de ladite methode
DE69736076D1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase-ähnlicher aktivität.
ATE310823T1 (de) Expressionssystem zur produktion von proteinen in pilzen
WO2001006019A3 (en) Nucleic acids for detecting parvovirus and methods of using same
Slon-Usakiewicz et al. Design of P1 ‘and P3 ‘Residues of Trivalent Thrombin Inhibitors and Their Crystal Structures
WO2002102847A1 (fr) Nouveau ligand et son adn
DE60225587D1 (de) Protease assay zur kontrolle medikamentöser therapie
NZ504633A (en) A dna molecule encoding a mutant prepro-neuropeptide y, a mutant signal peptide, and uses thereof
ATE510922T1 (de) Induzierbare promotoren
Ma et al. Proteolytic cleavage of the puromycin-sensitive aminopeptidase generates a substrate binding domain